144 related articles for article (PubMed ID: 1619383)
1. Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin.
Linde T; Sandhagen B; Danielson BG; Wikström B
J Intern Med; 1992 Jun; 231(6):601-6. PubMed ID: 1619383
[TBL] [Abstract][Full Text] [Related]
2. Treatment of renal anaemia with recombinant human erythropoietin results in decreased red cell uptake of 45Ca.
Linde T; Ronquist G; Sandhagen B; Wikström B; Frithz G; Pettersson L; Danielson BG
Nephron; 1994; 68(4):419-26. PubMed ID: 7870225
[TBL] [Abstract][Full Text] [Related]
3. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA
Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
[No Abstract] [Full Text] [Related]
4. Effect of erythropoietin treatment on tissue oxygenation in patients with severe transfusion dependent renal anaemia.
Landgraf H; Grützmacher P; Garcia-Bartels C; Bergmann M; Ehrly AM; Schoeppe W
Eur J Med; 1993; 2(7):393-7. PubMed ID: 8258026
[TBL] [Abstract][Full Text] [Related]
5. [Improvement of hemorheologic parameters in hemodialyzed patients treated with human recombinant erythropoietin].
Delamaire M; Durand F; Hamel D; Joyeux V; Lepogamp P; Genetet B
J Mal Vasc; 1991; 16(3):289-94. PubMed ID: 1940657
[TBL] [Abstract][Full Text] [Related]
6. Changes in rheology and red blood cell function under recombinant human erythropoietin therapy.
Schmidt R; Lerche D; Dörp E; Winkler R; Klinkmann H
Pol Arch Med Wewn; 1991 Jun; 85(6):384-90. PubMed ID: 1896402
[TBL] [Abstract][Full Text] [Related]
7. Rheological studies during treatment of renal anaemia with recombinant human erythropoietin.
Macdougall IC; Davies ME; Hutton RD; Coles GA; Williams JD
Br J Haematol; 1991 Apr; 77(4):550-8. PubMed ID: 2025581
[TBL] [Abstract][Full Text] [Related]
8. Rheology in whole blood and in red blood cells under recombinant human erythropoietin therapy.
Lerche D; Schmidt R; Zoellner K; Meier W; Paulitschke M; Distler B; Klinkmann H
Contrib Nephrol; 1989; 76():299-303; discussion 304-5. PubMed ID: 2684529
[No Abstract] [Full Text] [Related]
9. The required dose of erythropoietin during renal anaemia treatment is related to the degree of impairment in erythrocyte deformability.
Linde T; Sandhagen B; Wikström B; Danielson BG
Nephrol Dial Transplant; 1997 Nov; 12(11):2375-9. PubMed ID: 9394325
[TBL] [Abstract][Full Text] [Related]
10. Effects of erythropoietin on erythrocyte deformability in non-transfused preterm infants.
Klipp M; Holzwarth AU; Poeschl JM; Nelle M; Linderkamp O
Acta Paediatr; 2007 Feb; 96(2):253-6. PubMed ID: 17429915
[TBL] [Abstract][Full Text] [Related]
11. Increased whole blood viscosity combined with decreased erythrocyte fluidity in untreated patients with essential hypertension.
Sandhagen B; Frithz G; Waern U; Ronquist G
J Intern Med; 1990 Dec; 228(6):623-6. PubMed ID: 2280239
[TBL] [Abstract][Full Text] [Related]
12. Red cell membrane during erythropoietin therapy in hemodialysis and in hemodiafiltration.
Icardi A; Paoletti E; Traverso GB; Sarchi C; Cappelli G; Molinelli G
Int J Artif Organs; 1991 Mar; 14(3):147-9. PubMed ID: 2045188
[TBL] [Abstract][Full Text] [Related]
13. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
Schaefer RM; Heidland A
Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190
[No Abstract] [Full Text] [Related]
14. Haemorheological changes in uraemic children in response to erythropoietin treatment.
Böhler T; Leo A; Linderkamp O; Braun A; Schärer K
Nephrol Dial Transplant; 1993; 8(2):140-5. PubMed ID: 8384334
[TBL] [Abstract][Full Text] [Related]
15. Effect of hemodialysis and recombinant human erythropoietin on determinants of blood viscosity.
Shand BI; Buttimore AL; Lynn KL; Bailey RR; Robson RA
Ren Fail; 1994; 16(3):407-13. PubMed ID: 8059023
[TBL] [Abstract][Full Text] [Related]
16. Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin.
Baldamus CA; Steffen AM; Brunner R; Pollok M
Contrib Nephrol; 1990; 82():79-85. PubMed ID: 2093531
[No Abstract] [Full Text] [Related]
17. Long-term effects of rhEPO therapy on erythrocyte rheology in dialysis patients with different target hematocrits.
Paulitschke M; Ludat K; Riedel E; Hampl H
Clin Nephrol; 2000 Feb; 53(1 Suppl):S36-41. PubMed ID: 10746804
[TBL] [Abstract][Full Text] [Related]
18. The use of recombinant human erythropoietin in predialysis patients.
Besarab A; Ross RP; Nasca TJ
Curr Opin Nephrol Hypertens; 1995 Mar; 4(2):155-61. PubMed ID: 7600046
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of renal anemia with recombinant human erythropoietin].
Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
[TBL] [Abstract][Full Text] [Related]
20. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
